Wockhardt is currently trading at Rs. 303.10, up by 7.60 points or 2.57% from its previous closing of Rs. 295.50 on the BSE.
The scrip opened at Rs. 295.30 and has touched a high and low of Rs. 307.60 and Rs. 295.30 respectively. So far 112837 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 411.60 on 11-Feb-2020 and a 52 week low of Rs. 147.20 on 24-Mar-2020.
Last one week high and low of the scrip stood at Rs. 310.00 and Rs. 285.15 respectively. The current market cap of the company is Rs. 3360.37 crore.
The promoters holding in the company stood at 72.12%, while Institutions and Non-Institutions held 4.69% and 23.19% respectively.
Wockhardt has reported net loss at Rs 57.38 crore for the quarter ended September 30, 2020 as compared net profit of Rs 0.07 crore for the same quarter in the previous year. However, total income of the company marginally increased by 0.95% at Rs 309.92 crore for Q2FY21 as compared Rs 307.00 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported net profit attributable to equity holders at Rs 3.55 crore for the quarter ended September 30, 2020 as compared net loss of Rs 82.17 crore for the same quarter in the previous year. Total income of the company increased by 6.97% at Rs 730.29 crore for Q2FY21 as compared Rs 682.69 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1861.70 |
Dr. Reddys Lab | 1389.35 |
Cipla | 1506.15 |
Lupin | 2228.00 |
Zydus Lifesciences | 972.70 |
View more.. |